MEDIFAST INC — Form 10-Q
Filed October 26, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
Nicholas M. Johnson (CEO) and James P. Maloney (CFO) issued standard Sarbanes-Oxley certifications (Rules 13a-14(a) and Section 906) for the 10-Q period ended September 30, 2026, dated October 26, 2026. Both officers certified that financial statements fairly present the company's condition and operations, disclosure controls are effective, and no material weaknesses or fraud involving management were identified. This is routine quarterly certification with no new disclosures of control deficiencies or material changes.
Why this rating
Boilerplate SOX certification with no material exceptions; standard periodic disclosure. No new facts about business or controls disclosed.
See more from October 26, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.